These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32298746)
1. Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion. Chambers ST; Long M; Gardiner SJ; Chin PKL; Yi M; Dalton SC; Drennan PG; Metcalf SCL Int J Antimicrob Agents; 2020 Jun; 55(6):105972. PubMed ID: 32298746 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital. Norton K; Ingram PR; Heath CH; Manning L J Antimicrob Chemother; 2014 Mar; 69(3):805-8. PubMed ID: 24107387 [TBL] [Abstract][Full Text] [Related]
4. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. Cataldo MA; Tacconelli E; Grilli E; Pea F; Petrosillo N J Antimicrob Chemother; 2012 Jan; 67(1):17-24. PubMed ID: 22028203 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study. Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306 [TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy. Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*. Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis. Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion. Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263 [TBL] [Abstract][Full Text] [Related]
10. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration. Oda K; Jono H; Nosaka K; Saito H Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597 [TBL] [Abstract][Full Text] [Related]
11. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion. Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966 [TBL] [Abstract][Full Text] [Related]
12. Can we guarantee less nephrotoxicity when vancomycin is administered by continuous infusion? Echeverría-Esnal D; Marín-Casino M; Retamero A; Grau S Int J Antimicrob Agents; 2016 Jul; 48(1):116-117. PubMed ID: 27234679 [No Abstract] [Full Text] [Related]
13. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China. Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843 [TBL] [Abstract][Full Text] [Related]
15. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study. de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314 [TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program. Shakeraneh P; Fazili T; Wang D; Gilotra T; Steele JM; Seabury RW; Miller CD; Darko W; Probst LA; Kufel WD Pharmacotherapy; 2020 Apr; 40(4):357-362. PubMed ID: 32090347 [TBL] [Abstract][Full Text] [Related]
19. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis. Horey A; Mergenhagen KA; Mattappallil A Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306 [TBL] [Abstract][Full Text] [Related]
20. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Matson KL; Shaffer CL; Beck GL; Simonsen KA Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]